CLINICAL_TRIALS
trial_result
· 2021-01-05
Clinical Trial Update: A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based [Phase 3]
Summary
Phase 3 trial in maintenance kidney transplant recipients after conversion to belatacept (Nulojix) completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Kidney Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2021-01-05